Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application symbols : GLAXF save search
Wilms Tumor Protein Global Market Report 2024, by Product Type, Detection Method (Immunohistochemistry; Enzyme-Linked Immunosorbent Assay; Western Blotting; PCR), Application and End-User
Published: 2024-02-22 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -0.0%
TMO | News | $577.39 0.49% -0.38% 1.7M
|
Health Technology
|
| O: 0.39%
H: 1.03%
C: 0.99%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.69%
H: 1.42%
C: 1.22%
ABT | News | $106.89 -0.65% 0.07% 4.2M
|
Health Technology
|
| O: 0.9%
H: 0.97%
C: 0.78%
report tumor global protein application market
Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update
Published: 2022-07-28 (Crawled : 15:00) - biospace.com/
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: -2.13%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -1.54%
H: 0.91%
C: 0.14%
sdc-1801 application trial update
Renal Anemia Therapeutics Market Segmented by Application and Geography, Region, Size, Outlook, Share and Forecast 2022-2026 | Technavio
Published: 2022-05-18 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 400
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -2.66%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
AZN | News | $71.2 0.49% 0.46% 5.4M
|
Health Technology
|
| O: -1.92%
H: 0.5%
C: -1.4%
AMGN | News | $273.01 -0.19% -0.17% 1.5M
|
Health Technology
|
| O: 0.93%
H: 0.32%
C: -1.03%
application renal anemia therapeutics market
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19
Published: 2022-01-13 (Crawled : 15:30) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: 0.29%
H: 0.0%
C: 0.0%
XNCR | $19.02 3.54% 3.57% 760K
|
Health Technology
|
| O: 0.38%
H: 1.12%
C: -1.31%
VIR | $8.04 -1.11% -1.12% 770K
|
Health Technology
|
| O: 1.05%
H: 1.98%
C: -6.88%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
covid-19 treatment fda application covid authorization merge emergency use authorization
Global Drug Delivery Devices Market Research Report (2021 to 2026) - by Route of Administration, Vehicles, Application, End-user and Region
Published: 2022-01-04 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: -3.82%
H: 1.65%
C: 0.04%
WST | $385.73 -1.15% 0.0% 760K
|
Health Technology
|
| O: -0.79%
H: 0.66%
C: -3.03%
PANA 4 | $10.25 0.0% 110K
|
Finance
|
| O: 0.72%
H: 0.0%
C: -0.72%
PHG | News | $20.97 -0.19% 0.0% 650K
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.23%
H: 0.62%
C: -0.07%
BDX | $233.83 -0.23% 0.0% 780K
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
BAX | $40.93 -0.22% 0.0% 2.2M
|
Health Technology
|
| O: 0.13%
H: 1.18%
C: 1.17%
ABT | News | $106.89 -0.65% 0.07% 4.2M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
MMM | $92.02 -1.05% 0.17% 2.7M
|
Producer Manufacturing
|
| O: 0.1%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -2.03%
H: 0.0%
C: 0.0%
OSUR | News | $5.5 -0.54% -0.73% 880K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
PODD | $167.25 -0.01% -0.03% 660K
|
Health Technology
|
| O: 2.92%
H: 2.2%
C: -1.17%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: -2.51%
application drug device research liver vehicles drug delivery
FDA grants Priority Review to ViiV Healthcare’s New Drug Application for cabotegravir long-acting for prevention of HIV
Published: 2021-09-28 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: -1.15%
H: 0.49%
C: -0.07%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.73%
H: 0.13%
C: -0.44%
new drug fda drug hiv application granted grant
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.